| Literature DB >> 34088986 |
Juyoung Lee1,2, Vilhelmiina Parikka3,4, Liisa Lehtonen3,4, Hanna Soukka3,4.
Abstract
BACKGROUND: The physiological benefit of parent-infant skin-to-skin contact (SSC) is uncertain for preterm infants with ventilatory support. We aimed to investigate whether SSC stabilizes the respiration compared to incubator care in mechanically ventilated preterm infants.Entities:
Mesh:
Year: 2021 PMID: 34088986 PMCID: PMC8176875 DOI: 10.1038/s41390-021-01607-2
Source DB: PubMed Journal: Pediatr Res ISSN: 0031-3998 Impact factor: 3.953
Fig. 1Representative graph of the intervention and control periods.
The skin-to-skin contact (SSC) intervention was selected and first 10 min of data was excluded to secure a washout period. An equally length control period without handling or procedures was selected from the following night, between 11 p.m. and 5 a.m., while the infant was placed in the incubator. The beginning of the control period was matched with SSC in terms of the time since the previous feeding.
Baseline characteristics at the time of skin-to-skin contact.
| Total ( | Invasive NAVA ( | Non-invasive NAVA ( | |
|---|---|---|---|
| Day of life, day | 29 (1–85) | 32 (1–74) | 25 (5–85) |
| Postmenstrual age, weeks | 30+5 (25+2–35+6) | 30+5 (25+2–34+3) | 30+5 (25+2–35+6) |
| Body weight at study, g | 1270 (680–2600) | 1270 (680–2600) | 880 (690–2075) |
| Bronchopulmonary dysplasiaa | 140 (84) | 126 (91) | 14 (48) |
| Skin-to-skin contact duration, min | 166 (63–392) | 163 (63–392) | 175 (119–350) |
| Ventilator setting | |||
| FiO2, % | 27 (21–62) | 30 (21–62) | 21 (21–48) |
| PEEP, cmH2O | 5 (4–8) | 5 (4–8) | 6 (4–8) |
| NAVA level | 1.4 (0–2.0) | 1.5 (1.0–2.0) | 1.2 (0–2.0) |
| PIP limit, cmH2O | 30 (25–65) | 30 (25–35) | 40 (25–65) |
| Apnea time, s | 3.0 (1.6–10.0) | 3.0 (1.6–5.0) | 4.0 (2.0–10.0) |
| Backup rate, /min | 30 (16–40) | 30 (16–40) | 24 (16–30) |
Data presented as median (range) or n (%).
NAVA neurally adjusted ventilatory assist, FiO fraction of inspired oxygen, PEEP positive end-expiratory pressure, PIP peak inspiratory pressure.
aSupplemental oxygen at 36 weeks of postmenstrual age.
Respiratory parameter comparison between skin-to-skin contact and incubator care during invasive and non-invasive NAVA.
| Invasive NAVA ( | Non-invasive NAVA ( | |||||
|---|---|---|---|---|---|---|
| Skin-to-skin contact | Incubator care | Skin-to-skin contact | Incubator care | |||
| Peak Edi, μV | 8.7 ± 2.4 | 9.9 ± 2.5 | <0.001 | 8.6 ± 4.5 | 9.4 ± 5.0 | 0.035a |
| Minimum Edi, μV | 2.3 ± 0.8 | 2.7 ± 1.0 | <0.001 | 2.0 ± 0.7 | 2.4 ± 0.8 | 0.012a |
| Measured respiratory rate, /min | 48.9 ± 8.9 | 51.6 ± 8.3 | <0.001 | 52.2 ± 11.5 | 53.3 ± 10.7 | 0.426 |
| Neural respiratory rate, /min | 45.5 ± 12.7 | 48.7 ± 10.3 | <0.001 | 50.3 ± 13.1 | 51.5 ± 11.8 | 0.411 |
| Time on backup, %/min | 10.0 ± 10.0 | 14.2 ± 16.7 | 0.016a | 5.3 ± 7.2 | 6.6 ± 8.4 | 0.048a |
| Supplied oxygen, % | 31.2 ± 9.8 | 30.9 ± 9.5 | 0.397a | 29.3 ± 10.3 | 28.5 ± 8.1 | 0.888a |
| Peak inspiratory pressure, cmH2O | 16.5 ± 3.2 | 16.9 ± 3.1 | <0.001 | 14.5 ± 6.1 | 15.3 ± 4.7 | 0.042a |
| Positive end-expiratory pressure, cmH2O | 6.2 ± 0.9 | 6.3 ± 0.9 | 0.235 | 5.7 ± 1.2 | 5.8 ± 1.2 | 0.086 |
| Mean airway pressure, cmH2O | 9.8 ± 1.6 | 10.1 ± 1.6 | <0.001 | 8.7 ± 3.1 | 8.7 ± 2.9 | 0.581a |
| Expiratory tidal volume, ml/kg | 4.1 ± 1.8 | 3.5 ± 1.8 | <0.001 | 17.4 ± 13.8 | 18.4 ± 17.3 | 0.738a |
| Dynamic compliance, ml/cmH2O/kg | 0.43 ± 0.19 | 0.37 ± 0.21 | <0.001a | |||
Data presented as mean ± SD.
NAVA neurally adjusted ventilatory assist, Edi electrical activity of diaphragm.
aWilcoxon signed-rank test; otherwise paired T test.
Respiratory parameter comparison between skin-to-skin contact and incubator care under or above 28 weeks of postmenstrual age.
| <28 weeks of PMA ( | ≥28 weeks of PMA ( | |||||
|---|---|---|---|---|---|---|
| Skin-to-skin contact | Incubator care | Skin-to-skin contact | Incubator care | |||
| Peak Edi, μV | 7.3 ± 3.0 | 8.5 ± 3.0 | 0.027a | 9.0 ± 3.1 | 10.1 ± 3.0 | <0.001 |
| Minimum Edi, μV | 1.9 ± 1.0 | 2.2 ± 1.1 | 0.039a | 2.3 ± 0.8 | 2.7 ± 0.9 | <0.001 |
| Measured respiratory rate, /min | 47.4 ± 4.7 | 48.2 ± 5.3 | 0.429 | 49.8 ± 10.0 | 52.4 ± 9.1 | <0.001a |
| Neural respiratory rate, /min | 43.0 ± 8.9 | 43.1 ± 10.0 | 0.784a | 46.3 ± 13.4 | 50.2 ± 10.4 | <0.001a |
| Time on backup, %/min | 13.2 ± 13.7 | 14.3 ± 17.1 | 0.855a | 8.5 ± 8.1 | 12.8 ± 16.6 | 0.003a |
| Supplied oxygen, % | 24.0 ± 3.8 | 24.1 ± 5.6 | 0.408a | 32.0 ± 10.1 | 31.5 ± 9.4 | 0.426a |
| Peak inspiratory pressure, cmH2O | 11.9 ± 5.1 | 12.7 ± 5.1 | 0.138a | 16.9 ± 4.0 | 17.1 ± 3.8 | 0.024a |
| Positive end-expiratory pressure, cmH2O | 6.1 ± 0.9 | 6.2 ± 0.8 | 0.200 | 6.1 ± 0.9 | 6.2 ± 1.0 | 0.355 |
| Mean airway pressure, cmH2O | 8.4 ± 2.3 | 8.5 ± 2.2 | 0.484a | 9.8 ± 1.8 | 10.1 ± 1.8 | <0.001 |
| Expiratory tidal volume, ml/kg | 5.9 ± 3.5 | 6.2 ± 3.8 | 0.447a | 6.5 ± 8.3 | 6.1 ± 9.8 | <0.001a |
Data presented as mean ± SD.
PMA postmenstrual age, Edi electrical activity of diaphragm.
aWilcoxon signed-rank test; otherwise paired T test.
Comparison of hemodynamic changes between skin-to-skin contact and incubator care.
| Invasive NAVA | Non-invasive NAVA | |||||
|---|---|---|---|---|---|---|
| Skin-to-skin contact | Incubator care | Skin-to-skin contact | Incubator care | |||
| Desaturation, SpO2 < 80% | 39 (33.0) | 52 (37.7) | 0.096 | 4 (13.8) | 8 (27.6) | 0.331 |
| Bradycardia, HR < 80/min | 6 (4.3) | 12 (8.7) | 0.144 | 5 (17.2) | 3 (10.3) | 0.706 |
Data presented as numbers (%).
NAVA neurally adjusted ventilatory assist, HR heart rate.
aFisher’s exact test was used.